MAIA Biotechnology Inc. (MAIA)
AMEX: MAIA
· Real-Time Price · USD
1.59
0.06 (3.92%)
At close: Sep 24, 2025, 3:59 PM
1.58
-0.63%
After-hours: Sep 24, 2025, 07:48 PM EDT
3.92% (1D)
| Bid | 1.58 |
| Market Cap | 52.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -16.17M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -2.94 |
| Forward PE | -2.25 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.62 |
| Volume | 410,709 |
| Avg. Volume (20D) | 437,217 |
| Open | 1.56 |
| Previous Close | 1.53 |
| Day's Range | 1.53 - 1.64 |
| 52-Week Range | 1.40 - 3.48 |
| Beta | 0.03 |
| Ex-Dividend Date | n/a |
About MAIA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAIA
Website n/a
4 weeks ago
+7.14%
MAIA Biotechnology shares are trading higher after...
Unlock content with
Pro Subscription
2 months ago
+9.24%
MAIA Biotechnology shares are trading higher after the company announced it dosed its first patient in its Taiwan expansion stage of the THIO-101 Phase 2 trial.
3 months ago · https://www.marketscreener.com
MAIA Biotechnology, Inc. announced that it expects to receive $0.587904 million in funding from Prevail PartnersMAIA Biotechnology, Inc entered into a stock purchase agreement at maximum of 337,876 shares at a price $1.74 per share for gross proceeds $5,87,904.24 on June 26, 2025. The transaction included parti...